News
From a microfluidic system enabling enhanced CAR-T cell production to a digital tool facilitating the connection between healthcare professionals and families in underserved areas...
As a mutual and regional bank, Crédit Agricole Alpes Provence mobilizes its financial and human resources to support the economic development of its region, particularly, ...
The inaugural Skin Summit, held on April 24 and 25, 2025, in Juan-les-Pins by Eurobiomed as part of the Skin Excellence program, brought together the world's leading experts in dermatology...
The Nîmes University Hospital Center and Eurobiomed, Southern France's health competitiveness cluster, today announce the signing of a framework agreement aimed at strengthening their...
Guillaume Merlin, co-founder of Gapzen, reflects on his experience with Move2Digital, the digital transformation support service offered by InExtenso Innovation Croissance in...
From support for breastfeeding to assistance in managing medico-social establishments, the development of plant-based dermo-cosmetic ingredients, and...
Professor Thierry Passeron, University Professor, hospital practitioner at Université Côte d'Azur, Head of the Dermatology Department at Nice University Hospital (CHU de Nice), and Principal Investigator (PI) of a team at the CRM laboratory of...
Montpellier, April 7, 2025. Eurobiomed is pleased to announce the signing of a partnership agreement with the Montpellier University Innovation Cluster (PUI). The strengthening of...
Invest In Biomed est un programme unique d’Eurobiomed qui aide les entreprises innovantes en santé à consolider leur démarche et leurs outils de levée de fonds, et leur fait rencontrer les ...
Arnaud Debains and Sandrine Isz are respectively the Chief Financial Officer and Chief Science Officer of BOYDSense, a startup developing innovative respiratory analysis technology that enables patients to easily monitor their health status and manage chronic conditions, particularly diabetes. A laureate of Eurobiomed's Invest In Biomed program in 2023, BOYDSense successfully completed a fundraising round in April 2024.
Invest In Biomed est un programme unique d’Eurobiomed qui aide les entreprises innovantes en santé à consolider leur démarche et leurs outils de levée de fonds, et leur fait rencontrer les ...
Invest In Biomed est un programme unique d’Eurobiomed qui aide les entreprises innovantes en santé à consolider leur démarche et leurs outils de levée de fonds, et leur fait rencontrer les ...
No results found.